CI
Cellanome, Inc.
SEC filingBiotechnology · Foster City, CA
Amount raised$75.9Msold at filing
Total offering$75.9M
Investors in the raise22count reported to the SEC
FiledJun 22, 2026first sale Dec 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mehdi KhodadadExecutive Officer
Mostafa RonaghiDirector
Sandesh PatnamDirector
Omead OstadanExecutive Officer, Director
Rowan ChapmanDirector
Jay FlatleyDirector
Executive officers, directors and promoters as listed on the Form D.